KR20160139812A - Insulin injection apparatus and electronic device for communicating with the same - Google Patents

Abstract

Disclosed is an insulin injection device which comprises: a communication part requesting, if sensing completion of insulin injection, a bioinformation measurement device with measurement on bioinformation of a user and receiving the bioinformation from the bioinformation measurement device; a controlling part determining the status of the user based on the received bioinformation; and an outputting part outputting a determined outcome on the status.

Description

TECHNICAL FIELD [0001] The present invention relates to an insulin administration device and an electronic device communicating therewith,

Various embodiments relate to an apparatus for communicating with an insulin administration device and an insulin administration device, and more particularly to an electronic device that communicates with an insulin administration device and an insulin administration device that can determine insulin administration information based on the user's biometric information, An insulin administration device, and an electronic device communicating with an insulin administration device.

In general, diabetic patients lack insulin production ability to control their blood sugar level, and normal glucose control is not achieved. Accordingly, by administering insulin to a diabetic patient using an insulin administration device, the blood glucose level is maintained at a normal level.

Whether insulin is administered is determined by the results of the blood glucose measurement. The blood glucose is measured, the measured blood glucose level is compared with the normal blood glucose level, the insulin administration is determined, and the insulin is administered. The conventional insulin administration device injects a predetermined amount of insulin according to the items set by the manual operation of the user and does not consider the change in the health state of the patient in real time.

Various embodiments provide an insulin administration device and an insulin administration device that can determine insulin administration information in consideration of the user's biometric information and determine whether or not the insulin administration is abnormal based on the biometric information of the user after administration of the insulin, An electronic device can be provided.

The apparatus for insulin administration according to an embodiment of the present invention includes a communication unit for requesting measurement of a user's biometric information by a biometric information measuring device upon completion of insulin administration and receiving the biometric information from the biometric information measurement device, A controller for determining whether or not the user is abnormal, and an output unit for outputting a result of determining whether there is an abnormality.

The control unit sets insulin administration information based on the biometric information of the user measured before administration of the insulin and the insulin administration information for the user, and the insulin administration information includes information on the insulin administration time, type of insulin to be administered , An insulin dose, and a mixture ratio of insulin.

The communication unit according to an embodiment may receive the insulin prescription information from an external device.

The apparatus for insulin administration according to one embodiment may further include a user input unit for receiving insulin prescription information.

The output unit according to an exemplary embodiment may include a display unit that displays the set insulin administration information.

The output unit according to an exemplary embodiment may display the determination result on the display unit or output audio or vibration.

The apparatus for insulin administration according to one embodiment further includes a sensor unit for sensing whether or not a needle coupled to the insulin administration device is in contact with the user's body,

The control unit may determine that the administration of the insulin is completed when the needle is not in contact with the user's body for the time set by the user.

The control unit may determine that the insulin administration is completed when at least one of the administration of the insulin dosage amount included in the set insulin administration information and the reception of the insulin administration completion input is received.

A method of operating an insulin dispensing apparatus according to an exemplary embodiment includes detecting completion of insulin administration, requesting a user to measure a living body information with a living body information measuring apparatus, receiving the living body information from the living body information measuring apparatus, Determining whether there is an abnormality with respect to the user based on the biometric information, and outputting the determination result of the abnormality.

An electronic device according to an embodiment of the present invention receives information on completion of insulin administration from an insulin administration device, and upon receipt of the insulin administration completion information, requests a user's biometric information measurement by the biometric information measurement device, A communication unit for receiving biometric information, a control unit for determining whether the user is abnormal based on the received biometric information, and an output unit for outputting a result of determination as to whether or not there is an abnormality.

The electronic device may further include a storage unit for storing the insulin administration history information of the user, and the control unit may update the insulin administration history information when the insulin administration completion information is received.

The communication unit according to an embodiment may receive the insulin prescription information for the user from the prescription server.

The control unit may control the communication unit to transmit a message to the terminal set by the user when it is determined that there is an anomaly for the user as a result of the determination.

A method of operating an electronic device according to an exemplary embodiment of the present invention includes receiving insulin administration completion information from an insulin administration device, requesting a biometric information measurement device of a user for biometric information measurement upon receipt of the insulin administration completion information, Receiving the biometric information from the information measuring apparatus, determining whether the user is abnormal based on the received biometric information, and outputting a determination result on whether or not the user is abnormal.

According to one embodiment, appropriate insulin administration is possible depending on the patient's condition, by setting the dosage information based on the patient's condition, prior to administration of the insulin.

After insulin administration, it is possible to take appropriate measures against adverse reactions such as hypoglycemic symptoms after insulin administration by measuring the state of the patient, judging the abnormality, and feeding back the abnormality to the user.

IA is a diagram illustrating an insulin delivery system in accordance with one embodiment.
1B is a view showing the structure of an insulin administration device according to an embodiment.
FIG. 2 is a flowchart showing an operation method of the insulin administration device of FIG. 1;
FIG. 3 is a flow chart illustrating an operation method of the insulin administration system of FIG. 1;
4 is a diagram illustrating an insulin administration system in accordance with one embodiment.
5 is a flowchart showing an operation method of the electronic device of Fig.
FIG. 6 is a flowchart showing an operation method of the insulin administration system of FIG. 4;
FIG. 7 is a flowchart showing an operation method of the insulin administration device when the insulin administration information is manually set in step 650 of FIG. 6 (S 650).
8 is a diagram illustrating an insulin administration system according to one embodiment.
FIG. 9 is a flow chart showing an operation method of the insulin administration system of FIG. 8;
10 is a diagram illustrating an insulin administration system in accordance with one embodiment.
FIG. 11 is a flowchart showing an operation method of the insulin administration system of FIG. 10; FIG.
12 is a diagram showing an example in which insulin administration information is changed based on biometric information of a user according to an embodiment.
FIG. 13 is a diagram showing an example in which the insulin administration device according to an embodiment receives biometric information after completion of administration of insulin.
14 is a diagram showing an example in which insulin administration information is set based on biometric information of a user according to an embodiment.
15 is a view showing an example of manually setting insulin administration information according to one embodiment in an insulin administration device.
16 is a diagram showing an example in which an electronic device according to an embodiment receives biometric information after completion of insulin administration.
FIG. 17 is a view showing an example of feeding back the occurrence of side effects to a user when side effects due to administration of insulin according to one embodiment occur.
FIG. 18 is a diagram illustrating an example of transmitting a message to an external device to notify the occurrence of a side effect when a side effect of insulin administration according to an embodiment occurs.
19 and 20 are views showing an authentication method between an insulin administration device and an electronic device according to an embodiment.
21 is a block diagram showing a configuration of an insulin administration device according to an embodiment.
22 and 23 are block diagrams showing the configuration of an electronic device according to an embodiment of the present invention.

The terms used in this specification will be briefly described and the present invention will be described in detail.

While the present invention has been described in connection with what is presently considered to be the most practical and preferred embodiment, it is to be understood that the invention is not limited to the disclosed embodiments. Also, in certain cases, there may be a term selected arbitrarily by the applicant, in which case the meaning thereof will be described in detail in the description of the corresponding invention. Therefore, the term used in the present invention should be defined based on the meaning of the term, not on the name of a simple term, but on the entire contents of the present invention.

When an element is referred to as "including" an element throughout the specification, it is to be understood that the element may include other elements as well, without departing from the spirit or scope of the present invention. Also, the terms "part," " module, "and the like described in the specification mean units for processing at least one function or operation, which may be implemented in hardware or software or a combination of hardware and software .

Hereinafter, embodiments of the present invention will be described in detail with reference to the accompanying drawings so that those skilled in the art can easily carry out the present invention. The present invention may, however, be embodied in many different forms and should not be construed as limited to the embodiments set forth herein. In order to clearly illustrate the present invention, parts not related to the description are omitted, and similar parts are denoted by like reference characters throughout the specification.

IA is an illustration of an insulin delivery system, in accordance with one embodiment.

The insulin administration system according to one embodiment may include an insulin administration device 100 and a bio-information measurement device 50. [ The insulin administration device 100 refers to a device capable of injecting insulin into a patient. The structure of the insulin administration device 100 will be described later with reference to FIG. 1B. The insulin administration device 100 may include a pen-shaped insulin pen and a pump-type insulin pump. However, the present invention is not limited thereto, and the insulin administration device can be implemented in various forms.

The insulin administration device 100 according to an embodiment may include a communication module capable of communicating with an external device or a server. For example, the insulin dispensing apparatus 100 may communicate with an external device or a server to receive a user's insulin prescription information (e.g., insulin administration information prescribed by a doctor). Alternatively, the insulin administration device 100 may communicate with the biometric information measurement device 50 to request the biometric information measurement device 50 to measure the user's biometric information, Information can be received. For example, the insulin administration device 100 can receive first biometric information sensed before insulin administration and second biometric information sensed after insulin administration.

The insulin administration apparatus 100 can set insulin administration information based on the insulin prescription information and the first biometric information of the user (biometric information sensed before insulin administration). The insulin administration information may include an insulin administration time, a kind of insulin to be administered, an insulin dose, a mixing ratio of different insulin (when mixed with different kinds of insulin), and the like. The insulin administration apparatus 100 can control the administration of insulin to the user according to the set insulin administration information.

The insulin administration apparatus 100 can determine the presence or absence of abnormality in insulin administration based on the second biometric information of the user (biometric information sensed after insulin administration).

The bio-information measuring device 50 according to an embodiment is a device for measuring bio-information according to an embodiment of the present invention. The bio-information measuring device 50 includes a user's biometric information (for example, user's body temperature, heart rate, pulse rate, pulse rate, blood pressure, sweat, blood glucose, respiration information, , Diet information, food amount information, stress information, sleep information, etc.). The biometric information measuring device 50 may include various sensors capable of measuring biometric information of a user. Further, the bio-information measuring device 50 may be implemented as a wearable device. For example, the bio-information measuring device 50 may be implemented as a wrist watch, a glass, a ring, a bracelet, a necklace, a headband, a patch, a clip, an earphone, a hat, a helmet,

In addition, the bio-information measuring device 50 may include a communication module capable of communicating with an external device or a server. For example, the bio-information measuring device 50 may communicate with the insulin dosing device 100 to receive the user's biometric information request from the insulin dosing device 100. The biometric information measuring device 50 can measure the biometric information of the user when receiving the biometric information request from the insulin administration device 100. [ Alternatively, the biometric information of the user can be measured and stored at a predetermined period without requiring the biometric information request. The biometric information measuring device 50 can transmit the biometric information to the insulin dosing device 100.

1B is a view showing the structure of an insulin administration device according to an embodiment.

Referring to FIG. 1B, the insulin administration device 100 includes a driving part 300 and a piston pushing part 400. The driving unit 300 includes a battery, and includes a motor, a control unit, and a display unit 350. The control unit receives the information input by the user and processes the received information to drive the motor. The driving unit 300 is coupled to the piston pushing unit 400 so that the rotational force of the motor can be transmitted to the piston pushing unit 400 through the gear box. For example, when the user presses the operation button 342, the control unit controls the rotation of the motor according to the set insulin administration information to control the administration of the desired amount of insulin. In addition, the display unit 350 may display insulin administration information such as an insulin dose.

The piston pushing part 400 includes a cartridge fixing body 460 and the cartridge 1 in which insulin is embedded can be detachably mounted on the cartridge fixing body 460. [ In addition, when the insulin administration device 100 is not used, the insulin administration device 100 can be protected by inserting the cover 101 into the piston pushing part 400.

Also, referring to FIG. 1B, the injection amount display body 250 is mounted in a hollow cylinder shape so as to be rotatable. On the upper side of the outer circumferential surface of the injection amount display body 250, an injection amount display portion in which the insulin injection amount according to the rotation angle is indicated at an equal interval is provided, and a knob portion for making the user easier to rotate is formed on the lower side.

The cartridge fixing body 260 is detachably coupled with the cartridge connecting member 220 and accommodates the cartridge 1 containing the insulin. A remaining amount confirmation hole for confirming the remaining amount of insulin in the cartridge 1 accommodated may be formed on the outer circumferential surface of the cartridge fixing body 260. [ The needle contact body 470 is fixed to the lower side of the cartridge fixing body 460 and is detachably coupled thereto. A needle can be coupled to the needle connector 460, and a needle coupled to the needle connector 460 can be inserted into the user's body to administer insulin to the user.

FIG. 2 is a flowchart showing an operation method of the insulin administration device of FIG. 1;

Referring to FIG. 2, the insulin administration apparatus 100 may receive the insulin prescription information and the first biometric information of the user (S210). For example, the insulin prescription information may be received from an external device or a server, or may be input by the user directly to the insulin administration device 100. [ The insulin prescription information may be information about the insulin to be administered to the user in order to maintain the blood sugar of the user, and the insulin administration apparatus 100 may be used to set the insulin administration information. The insulin prescription information may include, for example, insulin administration time, kind of insulin to be administered, insulin dose, mixing ratio of different insulin (when mixed with different kinds of insulin), and the like. However, the present invention is not limited to this, and various information related to insulin administration may be included in the insulin prescription information.

Further, the insulin administration device 100 can receive the first biometric information of the user from the biometric information measurement device 50. [ The first biometric information may be biometric information of a user sensed before the insulin administration. For example, the insulin administration apparatus 100 may request the user's biometric information measurement by the biometric information measurement apparatus 50 at the time of administration of the insulin or a predetermined time before the administration time of the insulin, The biometric information of the user can be received from the user.

The insulin administration apparatus 100 may set insulin administration information based on the insulin administration information and the first biometric information of the user (S220).

For example, the insulin dispensing apparatus 100 may be configured to determine, based on the first biometric information, whether or not at least one of insulin administration time, type of insulin to be administered, amount of insulin, The administration information can be set. For example, the insulin administration apparatus 100 can reduce the dose of insulin contained in the insulin prescription information by taking into account first biometric information such as blood glucose level, exercise time, and strength before the user's exercise, have. At this time, the insulin administration apparatus 100 can automatically set the changed administration information. Alternatively, the insulin administration apparatus 100 may display the changed administration information on the display unit. When the changed dosage information is displayed on the display unit, the user can confirm the changed dosage information and manually set the changed dosage information in the insulin administration device 100. [

In addition, when the format of the insulin administration information is different from the format of the insulin administration information used in the insulin administration device, the insulin administration device 100 changes the format of the insulin administration information into the format of the insulin administration information, Based on the information, the insulin administration information can be set. For example, in the case of the insulin prescribing information, the dose and the administration time are prescribed on the basis of the first insulin, but the insulin used in the insulin administration apparatus 100 is insufficient in the second insulin (for example, ), The insulin administration apparatus 100 can change the insulin prescription information (for example, the insulin dose, the insulin administration time, etc.) based on the second insulin. The insulin administration apparatus 100 can set insulin administration information based on the prescription information and the first biometric information changed on the basis of the second insulin.

The insulin administration apparatus 100 may control the administration of insulin to the user according to the set administration information (S230).

When insulin administration is completed, the insulin administration apparatus 100 can acquire the second biometric information of the user (S240).

For example, the insulin administration apparatus 100 may determine that the insulin administration has been completed if the injection port for administering the insulin is not contacted from the user's body for the time set by the user. Alternatively, when the set dose of insulin is administered to the user, it can be judged that the insulin administration has been completed. Alternatively, when the insulin administration completion input is received, it can be judged that the insulin administration has been completed.

When insulin administration is completed, the insulin administration device 100 requests the biometric information measurement device 50 to measure the biometric information, and acquires biometric information (second biometric information) of the user after insulin administration from the biometric information measurement device 50 . For example, the insulin administration apparatus 100 can receive the blood glucose level of the user after insulin administration from the biometric information measurement apparatus 50.

The insulin administration apparatus 100 may determine the presence or absence of an abnormality in insulin administration based on the acquired biometric information of the user and output a determination result (S250).

For example, when the blood glucose level of the user is less than the threshold value, the insulin administration apparatus 100 may determine that the blood glucose level is abnormal (a side effect has occurred) and display a side effect occurrence message on the display unit. Alternatively, the insulin administration device 100 can output audio, vibration, and the like indicating occurrence of a side effect.

FIG. 3 is a flow chart illustrating an operation method of the insulin administration system of FIG. 1;

Referring to FIG. 3, the insulin administration apparatus 100 may receive the insulin prescription information (S310). For example, the insulin prescription information may be received from an external device or a server, or may be input by the user directly to the insulin administration device 100. [ The insulin prescription information indicates information on insulin administration to the user, including the time of administration of insulin, the type of insulin to be administered, the dosage of insulin, the mixing ratio of insulin (when mixed with different kinds of insulin), and the like .

The insulin administration apparatus 100 may request the user's biometric information to the biometric information measurement apparatus 50 at a time point of the administration time or a predetermined time before the administration time (S320).

The biometric information measuring device 50 may measure the biometric information of the user in response to the biometric information request (S330), and measure and store the biometric information of the user at a predetermined period without the request of the biometric information.

The biometric information measuring device 50 may transmit the biometric information of the user to the insulin dosing device 100 (S340).

The insulin administration apparatus 100 may set insulin administration information based on the insulin administration information and the user's biometric information (S350). Step S350 of FIG. 3 corresponds to step S220 of FIG. 2, so a detailed description thereof will be omitted.

The insulin administration apparatus 100 controls the user to administer insulin according to the set administration information (S360). When the insulin administration is completed, the insulin administration apparatus 100 may request the biometric information measurement apparatus 50 to measure the biometric information (S370).

For example, the bio-information measuring device 50 may measure bio-information (e.g., blood glucose level, respiratory rate, pulse, etc.) related to the user's blood sugar (S375) (S380).

The insulin administration apparatus 100 can determine the presence or absence of an abnormality in insulin administration based on the user's biometric information received from the biometric information measurement apparatus 50 and output the determination result (S390). Since step 390 (S390) corresponds to step 250 (S250) of FIG. 2, a detailed description will be omitted.

4 is a diagram illustrating an insulin administration system in accordance with one embodiment.

The system according to one embodiment may include an insulin administration device 100, an electronic device 200, and a bio-information measurement device 50. Since the insulin administration device 100 and the biometric information measurement device 50 have been described in detail with reference to FIG. 1, the same description will be omitted.

The electronic device 200 according to an exemplary embodiment may be a mobile phone, a smart phone, a laptop computer, a tablet PC, an electronic book terminal, a digital broadcast terminal, a PDA (personal digital assistant), a portable multimedia player ), Navigation, MP3 player, digital camera, Internet Protocol Television (IPTV), DTV (Digital Television), CE device (e.g.

In addition, the electronic device 200 may be a wearable device that can be worn by a user. For example, the electronic device 200 can be a wristwatch, glass, ring, bracelet, necklace, headband, and the like.

The electronic device 200 according to one embodiment may include a communication module capable of communicating with an external device or server. For example, the electronic device 200 can communicate with an external device or a server to receive the user's insulin prescription information. Alternatively, the electronic device 200 may communicate with the bio-information measuring device 50 to request the bio-information of the user with the bio-information measuring device 50, and may transmit the user's biometric information from the bio- .

The electronic device 200 can set insulin administration information based on the insulin prescription information and the user's biometric information (first biometric information). The insulin administration information may include an insulin administration time, a kind of insulin to be administered, an insulin dose, a mixing ratio of insulin (when mixed with different kinds of insulin), and the like.

The electronic device 200 may communicate with the insulin administration device 100 to transmit the set administration information to the insulin administration device 100.

In addition, the electronic device 200 can determine whether a side effect on insulin administration has occurred, based on the biometric information of the user (second biometric information) measured by the biometric information measuring device 50 after insulin administration.

5 is a flowchart showing an operation method of the electronic device of Fig.

Referring to FIG. 5, the electronic device 200 may receive insulin prescription information and biometric information of a user (S510). For example, the insulin prescription information may be received from an external device or a server, or may be input directly to the electronic device 200 by a user.

Further, the electronic device 200 can receive the user's first biometric information from the biometric information measurement device 50. [ For example, at the time of administration of the insulin or a predetermined time before the administration time of the insulin, the biometric information measuring device 50 requests the user's biometric information measurement, Information can be received.

The electronic device 200 can set insulin dosing information based on the insulin prescription information and the first biometric information of the user (S520).

For example, based on the first biometric information, the electronic device 200 can determine the insulin administration time, the type of insulin to be administered, the amount of insulin administered, and the mixing ratio of the insulin (mixing of different kinds of insulin The administration information can be set to at least one of the administration information. For example, the electronic device 200 can reduce the dosage of insulin contained in the insulin prescription information and set the administration information in consideration of the first biometric information such as blood glucose level, exercise time, and strength before the user's exercise .

The electronic device 200 may transmit the modified dosage information to the insulin administration device 100 (S530). Alternatively, the electronic device 200 may display the changed dosage information on the display portion of the electronic device 200. When the changed dosage information is displayed on the display unit, the user can confirm the changed dosage information and set the changed dosage information in the insulin administration device 100. [

In addition, the electronic device 200 may receive the administration completion information from the insulin administration apparatus 100 or may receive the user input to detect the completion of administration of the insulin (S540).

When the completion of insulin administration is detected, the electronic device 200 can acquire biometric information of the user after insulin administration (S550).

For example, the electronic device 200 can request biometric information measurement by the biometric information measurement device 50 and receive biometric information of the user after insulin administration from the biometric information measurement device 50. For example, the electronic device 200 may receive the blood glucose value of the user from the bio-information measurement device 50. [ Alternatively, the user may directly input the user's biometric information measured by the biometric information measuring device 50 into the electronic device 200. [

The electronic device 200 may determine whether a side effect of insulin administration has occurred based on the biometric information of the user after administration of the received insulin, and may output a determination result (S560).

For example, the electronic device 200 may determine that a side effect has occurred (abnormal state) when the blood glucose level of the user is below a threshold value (for example, a blood glucose level of less than 80 mg / dL) (E.g., a menu, an icon, a text, an item, etc.) on the display unit 221. [ Alternatively, the electronic device 200 may output audio, vibration, or the like indicating occurrence of a side effect. Alternatively, the electronic device 200 may transmit a side effect occurrence message to a predetermined external device.

FIG. 6 is a flowchart showing an operation method of the insulin administration system of FIG. 4;

Referring to FIG. 6, the electronic device 200 may acquire insulin prescription information (S610).

For example, the insulin prescription information may be received from an external device or a server, or may be input directly to the electronic device 200 by a user. The insulin prescription information indicates information on insulin administration to the user, including the time of administration of insulin, the type of insulin to be administered, the dosage of insulin, the mixing ratio of insulin (when mixed with different kinds of insulin), and the like .

The electronic device 200 may request the user's biometric information to the biometric information measuring device 50 at a time point of the administration time or a predetermined time before the administration time (S620).

The biometric information measuring device 50 may measure the biometric information of the user in response to the biometric information request (S630), and measure and store the biometric information of the user at a predetermined period without the request of the biometric information.

The biometric information measuring device 50 may transmit the biometric information of the user to the electronic device 200 (S635).

The electronic device 200 can set insulin administration information based on the insulin prescription information and the received biometric information of the user (S640). Since step 640 (S640) corresponds to step 520 (S520) of FIG. 5, a detailed description will be omitted.

The electronic device 200 may transmit the insulin administration information to the insulin administration device 100 (S645). Alternatively, the electronic device 200 may display the changed dosage information on the display portion of the electronic device 200.

The insulin administration apparatus 100 automatically sets the administration information received from the electronic device 200 (S650), and displays the received administration information on the display unit. When the changed dosage information is displayed on the display unit, the user can confirm the changed dosage information and manually set the changed dosage information.

The insulin administration apparatus 100 can administer insulin to the user according to the set administration information (S655).

The insulin administration apparatus 100 may transmit the administration completion information to the electronic device 200 when insulin administration is completed (S660). When the electronic device 200 receives the administration completion information from the insulin administration device 100, the electronic device 200 may request the biometric information measurement device 50 to measure the user's biometric information (S665). Accordingly, the bio-information measuring device 50 measures the user's biometric information (S667) and transmits the bio-information to the electronic device 200 (S670). For example, the bio-information measuring device 50 may transmit the blood glucose value of the user to the electronic device 200.

The electronic device 200 can determine the presence or absence of abnormality in insulin administration based on the received biometric information of the user, and output the determination result (S680). Since step 680 (S680) corresponds to step 560 (S560) of FIG. 5, a detailed description will be omitted.

FIG. 7 is a flowchart showing an operation method of the insulin administration device when the insulin administration information is manually set in step 650 of FIG. 6 (S 650).

The insulin administration apparatus 100 according to an embodiment may receive the first administration information (S710). For example, the first administration information may be insulin administration information set in the electronic device 200.

The insulin administration apparatus 100 may receive the second administration information (S720). For example, the second administration information may be administration information entered by the user into the insulin administration device 100. [

The insulin administration apparatus 100 may determine whether the first administration information and the second administration information are consistent within a predetermined range (S730).

If the first administration information and the second administration information do not match within a predetermined range, the insulin administration apparatus 100 may display a notification message (S740). For example, a message may be displayed on the display unit indicating that the administration information has been entered incorrectly.

On the other hand, if the first administration information and the second administration information match within a predetermined range, the insulin administration apparatus 100 may set the second administration information to the insulin administration information (S750).

8 is a diagram illustrating an insulin administration system according to one embodiment.

The insulin administration system according to one embodiment may include an insulin administration device 100, a bio-information measurement device 50 and a server 300. Since the insulin administration device 100 and the biometric information measurement device 50 have been described in detail with reference to FIG. 1, the same description will be omitted.

The server 300 according to one embodiment may be a prescription server or a Clinical Decision Support System (CDSS) server. The prescription server is a server that manages a prescription of a user. The prescription server receives and stores a prescription of a user from a medical staff, and can transmit a prescription of the user to the user's electronic device 200 or the insulin administration device 100.

The CDSS server is a server for providing the necessary medical knowledge to determine the best solution and providing the derived solution to the user when the doctor decides and determines the diagnosis or the treatment policy for the specific problem of the patient .

The server 300 according to one embodiment may include a communication module capable of communicating with the insulin administration device 100 or the biometric information measurement device 50. For example, the server 300 may transmit the insulin administration information to the insulin administration apparatus 100 and may receive the user's biometric information from the insulin administration apparatus 100 or the biometric information measurement apparatus 50.

The server 300 can change the insulin prescription information based on the received biometric information of the user. In addition, the modified insulin prescription information can be transmitted to the insulin administration apparatus 100.

FIG. 9 is a flow chart showing an operation method of the insulin administration system of FIG. 8;

Referring to FIG. 9, the insulin administration apparatus 100 may receive the insulin administration information (S910). For example, the insulin prescription information may be received from an external device or server 300, or may be entered by the user directly into the insulin administration device 100. The insulin prescription information indicates information on insulin administration to the user, including the time of administration of insulin, the type of insulin to be administered, the dosage of insulin, the mixing ratio of insulin (when mixed with different kinds of insulin), and the like .

The insulin administration apparatus 100 may request the user's biometric information to the biometric information measurement apparatus 50 at a time point of the administration time or a predetermined time before the administration time (S920).

The biometric information measuring device 50 measures the user's biometric information in response to the biometric information request (S925), and can measure and store the biometric information of the user at a predetermined period without the request of the biometric information.

The biometric information measuring device 50 can transmit the biometric information of the user to the insulin dosing device 100 (S930).

The insulin administration apparatus 100 can transmit the biometric information of the user received from the biometric information measurement apparatus 50 to the server 300. [ Alternatively, the bio-information measuring device 50 can transmit the biometric information of the user to the server 300. [

The server 300 can change the insulin prescription information of the user based on the received biometric information of the user (S940). For example, the server 300 may change the insulin prescription information by reducing the dosage of insulin contained in the insulin prescription information, taking into account the blood glucose level, exercise time, and strength before the user's exercise. The server 300 may transmit the changed prescription information to the insulin administration apparatus 100 (S945).

The insulin administration apparatus 100 can set insulin administration information according to the changed prescription information. At this time, the insulin administration apparatus 100 can automatically set the changed prescription information (S950). Alternatively, the insulin administration apparatus 100 may display the changed prescription information on the display unit. When the changed prescription information is displayed on the display unit, the user can confirm the changed insulin prescription information and manually set the insulin administration information.

The insulin administration apparatus 100 may control the administration of insulin to the user according to the set administration information (S955).

When insulin administration is completed, the insulin administration apparatus 100 requests biometric information measurement by the biometric information measurement apparatus 50 (S960), and the biometric information measurement apparatus 50 measures the biometric information of the user after administration of the insulin (S962).

The insulin administration apparatus 100 can receive biometric information from the biometric information measurement device 50 (S965). For example, the insulin administration apparatus 100 can receive the blood glucose level of the user from the biometric information measurement apparatus 50. [

The insulin administration apparatus 100 can determine the presence or absence of an abnormality based on the acquired biometric information of the user and output the determination result (S970).

For example, if the blood glucose level of the user is less than the threshold value, the insulin administration apparatus 100 may determine that the blood glucose level of the user is abnormal (a side effect has occurred) ) Can be displayed. Alternatively, the insulin administration device 100 can output audio, vibration, and the like indicating occurrence of a side effect.

10 is a diagram illustrating an insulin administration system in accordance with one embodiment.

The insulin administration system according to one embodiment may include an insulin administration device 100, an electronic device 200, a bio-information measurement device 50, and a server 300.

Referring to FIG. 10, the electronic device 200 may include a communication module to perform communication with the server 300, the insulin administration device 100, and the bio-information measurement device 50. For example, the electronic device 200 may communicate with an external device or server 300 to receive the user's insulin prescription information. Alternatively, the electronic device 200 may communicate with the bio-information measuring device 50 to request the bio-information of the user with the bio-information measuring device 50, and may transmit the user's biometric information from the bio- .

The server 300 can receive the biometric information of the user from the electronic device 200 or the biometric information measuring device 50. [ The server 300 can change the insulin prescription information of the user based on the received biometric information of the user. In addition, the changed insulin prescription information can be transmitted to the electronic device 200. [

FIG. 11 is a flowchart showing an operation method of the insulin administration system of FIG. 10; FIG.

Referring to FIG. 11, the electronic device 200 may receive insulin prescription information (S1110).

For example, the insulin prescription information may be received from an external device or server 30, or may be entered directly into the electronic device 200 by a user. The insulin prescribing information indicates information on insulin administration to the user, including the time of administration of insulin, the type of insulin to be administered, the dosage of insulin, and the mixing ratio of insulin (when mixed with different types of insulin) can do.

The electronic device 200 may request the user's biometric information to the biometric information measuring device 50 at a time point of the administration time or a predetermined time before the administration time (S1115).

The biometric information measuring apparatus 50 measures the biometric information of the user in response to the biometric information request (S1120), and can measure and store the biometric information of the user at a predetermined period without the request of the biometric information.

The biometric information measuring device 50 may transmit the biometric information of the user to the electronic device 200 (S1125).

The electronic device 200 can transmit the biometric information of the user received from the biometric information measuring device 50 to the server 300 (S1130). Alternatively, the bio-information measuring device 50 can transmit the biometric information of the user to the server 300. [

The server 300 can change the insulin prescription information of the user based on the received biometric information of the user (S1135). For example, the server 300 may change the insulin prescription information by reducing the amount of insulin contained in the prescription information, taking into account the blood glucose level, exercise time, and strength before the user's exercise. The server 300 may transmit the changed insulin prescription information to the electronic device 200 (S1140).

The electronic device 200 can set the insulin administration information based on the changed prescription information (S1145).

The electronic device 200 may transmit the administration information to the insulin administration device 100 (S1150). Alternatively, the electronic device 200 may display the dosing information on the display of the electronic device 200. When the administration information is displayed on the display unit, the user can confirm the administration information and set the changed administration information in the insulin administration apparatus 100 (S1155).

The insulin administration apparatus 100 may control the administration of insulin to the user according to the set insulin administration information (S1160).

When insulin administration is completed, the insulin administration apparatus 100 may request the bio-information measurement device 50 to measure bio-information (S1165). Alternatively, the electronic device 200 may receive the administration completion information from the insulin administration device 100, receive the user input, detect completion of insulin administration, and request the biometric information measurement device 50 to measure the biometric information .

Accordingly, the bio-information measuring device 50 measures the bio-information of the user (S1167), and can transmit the measured bio-information to the electronic device 200. [ For example, the electronic device 200 may receive the blood glucose value of the user from the bio-information measurement device 50. [ The electronic device 200 can determine the presence or absence of abnormality in insulin administration based on the received biometric information of the user and output the determination result (S1175).

For example, when the blood glucose level of the user is less than the threshold value, the electronic device 200 determines that the user is abnormal (a side effect occurs) and displays a graphical element (e.g., a menu, an icon, Can be displayed. Alternatively, the electronic device 200 may output audio, vibration, or the like indicating occurrence of a side effect. Alternatively, the electronic device 200 may transmit a side effect occurrence message to a predetermined external device.

12 is a diagram showing an example in which insulin administration information is changed based on biometric information of a user according to an embodiment.

Referring to FIG. 12, the insulin administration apparatus 100 may receive the insulin prescription information 1210. As shown in FIG. 12, the insulin administration information 1210 includes information on the insulin administration time, type of insulin to be administered, dosage of insulin, insulin mixture ratio (different types of insulin, When insulin is mixed and administered), and the like. The insulin administration apparatus 100 can receive the insulin administration information from an external device or a server and automatically set insulin administration information according to the received prescription information. Alternatively, the user can input insulin prescription information directly into the insulin administration device 100, and set insulin administration information.

For example, as shown in FIG. 12, the insulin administration apparatus 100 can set the administration time, the type of insulin to be administered, the amount of insulin, and the mixing ratio of insulin, The administration information 1220 can be displayed on the display unit.

On the other hand, when the insulin administration apparatus 100 reaches the administration time or a certain time before the administration time, the biometric information measurement apparatus 50 can request the user's biometric information. Alternatively, the biometric information measuring device 50 can request the user's biometric information by user input.

The biometric information measuring device 50 may transmit the measured biometric information of the user to the insulin dosing device 100 in response to the biometric information request. For example, the bio-information measuring device 50 may measure the body temperature, heart rate, pulse, pulse rate, blood pressure, sweat, blood glucose, respiration information, oxygen saturation, skin condition, exercise amount information, Sleeping information and the like can be transmitted to the insulin administration apparatus 100.

The insulin administration apparatus 100 can change the insulin administration information based on the received biometric information of the user. For example, the insulin dispensing device 100 can determine the dosage of insulin, taking into account the user's pre-exercise blood glucose level, exercise time, and strength. If the initial insulin dose is 20 units and the user has a pre-exercise blood glucose level of 100 mg / dL and the user has been running for 40 minutes (medium intensity high intensity exercise), the insulin dosing device 100 may be administered a set insulin dose The amount can be changed from 20 units to 19 units with 1 unit reduced. However, the present invention is not limited thereto, and the insulin administration device 100 may change the time of insulin administration, the type of insulin to be administered, and the like based on the first biometric information of the user (biometric information sensed before insulin administration).

The insulin administration apparatus 100 can automatically change the insulin administration information and display the changed insulin administration information 1230 on the display unit, as shown in Fig.

FIG. 13 is a diagram showing an example of receiving biometric information after the insulin administration device 100 according to one embodiment completes administration of insulin.

Referring to FIG. 13, when insulin administration is completed, the insulin administration apparatus 100 may display a message 1310 indicating completion of insulin administration on the display unit. Alternatively, audio, vibration, etc. indicating completion of insulin administration may be output.

The insulin administration apparatus 100 can determine that the insulin administration has been completed when the injection port for administering the insulin is not in contact with the user's body for a predetermined time and the set insulin dose is administered to the user. Alternatively, when the insulin administration completion input is received, it can be judged that the insulin administration has been completed.

When insulin administration is completed, the insulin administration device 100 can request biometric information measurement by the biometric information measurement device 50 and receive biometric information from the biometric information measurement device 50. For example, the insulin administration apparatus 100 can receive the blood glucose level of the user from the biometric information measurement apparatus 50. [ Also, the insulin administration device 50 may display information on the blood glucose level of the received user and the normal range of the expected blood glucose level 1320 after administration of the insulin on the display unit. Also, the insulin administration apparatus 100 can compare the blood glucose level of the current user with the normal range of the blood sugar level to determine whether or not the insulin administration is abnormal.

14 is a diagram showing an example in which insulin administration information is set based on biometric information of a user according to an embodiment.

Referring to FIG. 14, the electronic device 200 may receive insulin prescription information. As shown in FIG. 14, the insulin prescription information 1410 may include an administration time of insulin, a kind of insulin to be administered, a dose of insulin, and the like. The electronic device 200 can receive insulin administration information from an external device or a server. Alternatively, the user may directly input the insulin prescription information to the electronic device 200. [

As shown in Fig. 14, the electronic device 200 can display the obtained insulin prescription information 1410 on the display unit. The insulin prescription information may include the time of administration of insulin, the type of insulin to be administered, the dosage of insulin, the mixing ratio of insulin (when mixed with different kinds of insulin), and the like.

On the other hand, when the electronic device 200 arrives at a time before the administration time or a certain time before the administration time, the biometric information measuring device 50 can request the user's biometric information. Alternatively, the electronic device 200 may display on the display unit a message 1420 for selecting whether to request biometric information, as shown in Fig. At this time, the electronic device 200 can receive the user input for selecting the 'Yes' button, and request the user's biometric information to the biometric information measuring device 50.

The biometric information measuring device 50 may transmit the measured biometric information of the user to the electronic device 200 in response to the biometric information request. For example, the bio-information measuring device 50 may measure the body temperature, heart rate, pulse, pulse rate, blood pressure, sweat, blood glucose, respiration information, oxygen saturation, skin condition, exercise amount information, Sleeping information and the like can be transmitted to the electronic device 200.

The electronic device 200 can set the insulin administration information 1430 based on the prescription information and the biometric information of the user. For example, the electronic device 200 may determine the dosage of insulin, taking into account the user's pre-exercise blood glucose level, exercise time, and strength. If the initially set insulin dose is 20 units and the user has a pre-exercise blood glucose level of 100 mg / dL and the user has been running for 40 minutes (medium intensity high intensity exercise), then the electronic device 200 will adjust the dosage of insulin You can change from 20 units to 19 units with 1 unit reduced. However, the present invention is not limited thereto, and the electronic device 200 can change the time of administration of insulin, the type of insulin to be administered, and the like based on the biometric information of the user.

Further, the electronic device 200 may transmit the insulin administration information to the insulin administration device 100. [

The insulin administration apparatus 100 may display the received insulin administration information 1440 on the display unit. Further, when the insulin administration apparatus 100 receives the input of pressing the OK button, the insulin administration apparatus 100 can set the insulin administration information displayed on the display unit.

15 is a view showing an example of manually setting insulin administration information according to one embodiment in an insulin administration device.

Referring to FIG. 15, the electronic device 200 may display insulin administration information 1510 on the display unit and may transmit the insulin administration information to the insulin administration apparatus 100.

The user can directly input insulin administration information into the insulin administration apparatus 100 and set insulin administration information. At this time, the insulin administration apparatus 100 compares the input insulin administration information 1520 with the received insulin administration information from the electronic device 100. When the insulin administration information is different, a message 1530 Can be displayed on the display unit.

16 is a diagram showing an example in which an electronic device according to an embodiment receives biometric information after completion of insulin administration.

Referring to FIG. 16, the insulin administration apparatus 100 may transmit information on completion of insulin administration to the electronic device 200 when insulin administration is completed. The insulin administration completion information may be data or a signal indicating that insulin administration has been completed. When the insulin administration completion information is received, the electronic device 200 may display a graphic element (e.g., menu, icon, text, item, etc.) 1620 indicating completion of insulin administration on the display unit 221. Alternatively, audio, vibration, etc. indicating completion of insulin administration may be output.

When the insulin administration is completed, the electronic device 200 can request biometric information measurement by the biometric information measurement device 50 and receive biometric information from the biometric information measurement device 50. For example, the electronic device 200 may receive the blood glucose value of the user from the bio-information measurement device 50. [ In addition, the electronic device 200 may display information on the blood glucose level of the receiving user and the normal range of the expected blood glucose level (1630) on the display unit after insulin administration. Also, the electronic device 200 can compare the blood glucose level of the current user with the normal range of the blood glucose level to determine whether or not the insulin administration is abnormal.

FIG. 17 is a view showing an example of feeding back the occurrence of side effects to a user when side effects due to administration of insulin according to one embodiment occur.

Referring to FIG. 17A, the electronic device 200 determines whether the blood glucose level of the current user is within the normal range (80 mg / dL to 150 mg / dL). If the blood glucose level is outside the normal range, can do. For example, if the blood glucose level of the current user is below the normal range, the user can be judged to be hypoglycemic.

Accordingly, the display unit of the electronic device 200 can display a result of the determination as to whether a side effect has occurred, which indicates that the user is in a hypoglycemic state, as graphic elements (e.g., a menu, icon, text, item, Can be displayed together with the blood glucose level. In addition, the electronic device 200 can output audio, vibration, etc. indicating that it is in a hypoglycemic state.

17 (b), the insulin administration apparatus 100 also determines the presence or absence of an abnormality in insulin administration in the same manner as the electronic device 200 of FIG. 17 (a) (1720), audio, vibration, and the like.

FIG. 18 is a diagram illustrating an example of transmitting a message to an external device to notify the occurrence of a side effect when a side effect of insulin administration according to an embodiment occurs.

18, when a first user becomes hypoglycemic after insulin administration, a first user's electronic device (first electronic device) 200 sends a determination result indicating that the first user is in a hypoglycemic state to a graphical element A menu, an icon, a text, an item, etc.), audio, vibration, and the like. Also, the first electronic device 200 may transmit a message to the external terminal 400 indicating that the first user is in the hypoglycemic state. For example, if a first user stores identification information of a terminal or family member to be contacted when a side effect occurs, the first electronic device 200 can transmit a message to the corresponding terminal. Alternatively, the first electronic device 200 may send a message to a predetermined emergency medical center. Alternatively, the first electronic device 200 may transmit a message to a terminal having the closest distance among the external terminals storing the identification information in the first electronic device 200.

19A, 19B and 20 are views showing an authentication method between an insulin administration device and an electronic device according to an embodiment.

Figures 19A and 19B illustrate a method for authenticating an insulin dispensing device 100 in an electronic device 200 according to one embodiment.

Referring to FIG. 19A, the insulin administration apparatus 100 and the electronic device 200 can generate and store a key for authentication (S 1905, S 1910). The insulin administration apparatus 100 according to an embodiment may transmit the identification information of the insulin administration apparatus 100 while requesting authentication with the electronic apparatus 200 (S1920). Alternatively, the electronic device 200 may transmit the identification information of the electronic device 200, while requesting authentication with the insulin administration device 100.

Meanwhile, the electronic device 200 receiving the authentication request can transmit a random value to the insulin administration device 100 (S1930).

The insulin administration apparatus 100 can encrypt the received random value by using a previously generated key or a key downloaded from the authentication server (S1940), and transmits the encrypted value to the electronic device 200 (S1950). At this time, the symmetric key method or the public key method can be used as the encryption method.

The electronic device 200 receives the encrypted value and decrypts the received encrypted value using a previously stored key to determine whether the insulin administration device 100 is authenticated (S1960).

If the insulin dosing device is authentic, the electronic device 200 may transmit the insulin dosing information to the insulin dosing device 100 (S1970).

If the authentication of the insulin administration device fails, the electronic device 200 does not transmit the insulin administration information to the insulin administration device 100.

Although FIG. 19A illustrates and describes an embodiment in which the electronic device 200 authenticates the insulin administration device 100, the present invention is not limited thereto, and the insulin administration device 100 can authenticate the electronic device 200 .

Referring to FIG. 19B, the insulin administration apparatus 100 generates a PIN value and displays the generated pin value on the display unit (S1915).

The electronic device 200 receives the pin value (S1925) and transmits it to the insulin administration device 100 (S1935).

The insulin administration apparatus 100 can determine whether the electronic device 200 is authenticated by comparing the generated pin value with the PIN value received from the electronic device 200 (S1945).

When the electronic device 200 is authenticated, the insulin administration device 100 transmits authentication completion information to the electronic device 200 (S1955), and can receive the insulin administration information from the electronic device 200 (S1965) .

When the authentication of the electronic device 200 fails, the insulin administration device 100 does not receive the insulin administration information from the electronic device 200.

19B, an embodiment has been shown and described in which the PIN value is generated in the insulin administration device 100 and the electronic device 200 is authenticated based on the generated pin value. However, the present invention is not limited to this, 200), and authenticate the insulin administration device 100 based on the generated pin value.

Meanwhile, FIG. 20 shows a method in which the electronic device 200 and the insulin administration device 100 authenticate each other.

20, the insulin administration device 100 and the electronic device 200 may generate and store a key for authentication (S2010, S2015). The insulin administration device 100 according to one embodiment The electronic device 200 may transmit the identification information and the first random value of the insulin administration device 100 while requesting authentication (S2020).

The electronic device 200 can encrypt the received first random value using a previously generated key or a key downloaded from the authentication server (S2025).

The electronic device 200 may transmit the identification information of the electronic device 200, the second random value, and the encrypted first random value, while requesting authentication with the insulin administration device 100 (S2030).

The electronic device 200 receives the encrypted first random value and decrypts the encrypted first random value with a previously generated key to determine whether to authenticate the electronic device 200 (S2040).

When the electronic device 200 is authenticated, the insulin administration device 100 encrypts the received second random value by using a previously generated key or a key downloaded from the authentication server (S2045 ), And may transmit the encrypted second random value to the electronic device 200 (S2050).

The electronic device 200 receives the encrypted second random value and decrypts the encrypted second random value with a previously generated key to determine whether the insulin administration device 100 is authenticated (S2060).

When the insulin administration apparatus 100 is authenticated, the electronic device 200 may transmit the insulin administration information to the insulin administration apparatus 100 (S2070).

20, the insulin administration apparatus 100 has been illustrated and described as initiating the authentication process while requesting the authentication with the electronic device 200. However, the present invention is not limited to this, and the electronic device 200 may be connected to the insulin administration apparatus 100 The authentication process can be started while requesting the authentication.

19A, 19B, and 20 may be performed before the wireless communication (e.g., Wi-Fi, Bluetooth, etc.) between the insulin dosing device 100 and the electronic device 200 is connected, And can be performed after connection. When the insulin dosing device 100 or the electronic device 200 is authenticated through the authentication process, the electronic device 200 is not operated until the wireless communication connection between the insulin dosing device 100 and the electronic device 200 is stopped. Can transmit insulin administration information to the insulin administration device 100. [

21 and 22 are block diagrams showing the configuration of an insulin administration device according to an embodiment.

Referring to FIG. 21, the insulin administration apparatus 100 may include a communication unit 110, a control unit 120, and an output unit 130. However, not all illustrated components are required. The insulin administration device 100 may be implemented by more components than the components shown, or the insulin administration device 100 may be implemented by fewer components.

22, the insulin administration apparatus 100 according to an embodiment may further include a user input unit 150, a sensor unit (not shown), a control unit 120, and an output unit 130. [ 160 and a storage unit 170, as shown in FIG.

Hereinafter, the components will be described in order.

The communication unit 110 may include one or more components for the insulin administration device 100 to perform communication with an external device. For example, the communication unit 110 may include a Bluetooth communication unit, a near field communication unit, a WLAN communication unit, a Zigbee communication unit, an IrDA (IrDA) communication unit, a WFD Direct) communication unit, an UWB (ultra wideband) communication unit, and an Ant + communication unit, but the present invention is not limited thereto.

The communication unit 110 may receive at least one of the insulin prescription information, the insulin administration information, and the user's biometric information from an external device.

The control unit 120 can set insulin administration information using the insulin prescription information and the biometric information of the user sensed before insulin administration. The control unit 120 may control the display unit 140 to display the set insulin administration information. In addition, the control unit 120 can determine whether or not the insulin administration is abnormal by using the biometric information of the user sensed after insulin administration.

The output unit 130 may output the determination result determined by the control unit 120. [ For example, the output unit 130 may display the determination result on the display unit 140, output the determination result to the audio through the sound output unit 132, or output the vibration through the vibration motor 133 .

The user input unit 150 means a means for the user to input data for controlling the insulin administration device 100. For example, the user input unit 150 may include a button, a key pad, a dome switch, a touch pad (a contact type capacitance type, a pressure type resistive type, an infrared ray detection type, a surface ultrasonic wave conduction type, An integral type tension measuring method, a piezo effect method, etc.), a jog wheel, a jog switch, and the like, but is not limited thereto.

The insulin administration apparatus 100 according to an embodiment may receive the insulin prescription information or the insulin administration completion input through the user input unit 150.

The sensor unit 160 may include various sensors to detect the state of the insulin administration device 100 (for example, whether the insulin administration device 100 is administering insulin to the patient, whether the insulin administration device 100 is administering insulin Or whether the insulin administration apparatus 100 has administered the set insulin dose to the patient) or the peripheral condition of the insulin administration apparatus 100 and transmits the sensed information to the control unit 120. [ . The sensor unit 160 according to one embodiment can detect whether the needle coupled to the insulin administration device is in contact with the user's body. For example, the sensor unit 160 can detect whether the needle coupled to the insulin administration device contacts the user's body using an optical sensor, a contact sensor, or the like. Accordingly, the controller 120 can determine that the administration of insulin is completed when the needle is not in contact with the user's body for the time set by the user.

In addition, the sensor unit 160 may detect the remaining amount of insulin and transmit the sensed residual amount to the control unit 120. Accordingly, the control unit 120 can determine whether insulin is administered to the patient, and can also determine whether the set insulin dose has been administered. The storage unit 170 may store a program for processing and controlling the insulin administration apparatus 100, and may store input / output data. The storage unit 170 according to one embodiment may store the user's insulin administration history information. For example, the time of insulin administration (date, time, etc.), the type of insulin administered, the amount of insulin administered, and the like can be stored. In addition, the storage unit 170 may store the expiration date of the insulin contained in the insulin cartridge installed in the insulin administration apparatus 100. [ In addition, the storage unit 170 may store the available time, usable location, and available user information of the insulin administration apparatus 100.

Accordingly, when the current time is not the stored usable time, and the place where the insulin administration apparatus 100 is located is not a usable place where the insulin administration apparatus 100 is stored, the user information (for example, The fingerprint information, etc.) is different from the stored user information, the insulin administration apparatus 100 can be set to the lock mode.

On the other hand, if the current time is the stored available time, if the location where the insulin dispensing apparatus 100 is located is the same as the stored available location, the insulin dispensing apparatus 100 may transmit the received user information (e.g., Face, gated room, fingerprint information, etc.) is the same as the stored user information, the lock mode of the insulin dosing device can be released.

23 and 24 are block diagrams showing the configuration of an electronic device according to an embodiment of the present invention.

Referring to FIG. 23, the electronic device 200 may include a communication unit 210, a control unit 230, and an output unit 220 according to an embodiment of the present invention. However, not all illustrated components are required. The electronic device 200 may be implemented by fewer components than the components shown, or may be implemented by fewer components.

24, the electronic device 200 according to an embodiment of the present invention includes a communication unit 210, a control unit 230, an output unit 220, a user input unit 240, an A / V input section 260 and a storage section 270. [

Hereinafter, the components will be described in order.

The communication unit 210 may include one or more components for performing communication between the electronic device 100 and an external device (for example, a server, an insulin dosing device, a bio-information measuring device, and the like). For example, the communication unit 210 may include a short-range communication unit 211, a mobile communication unit 212, and a broadcast reception unit 213.

The short-range wireless communication unit 211 includes a Bluetooth communication unit, a near field communication unit, a WLAN communication unit, a Zigbee communication unit, an IrDA (infrared data association) communication unit, A WFD (Wi-Fi Direct) communication unit, an UWB (ultra wideband) communication unit, an Ant + communication unit, and the like.

The mobile communication unit 212 transmits and receives a radio signal to at least one of a base station, an external terminal, and a server on a mobile communication network. Here, the wireless signal may include various types of data depending on a voice call signal, a video call signal, or a text / multimedia message transmission / reception.

The broadcast receiving unit 213 receives broadcast signals and / or broadcast-related information from outside through a broadcast channel. The broadcast channel may include a satellite channel and a terrestrial channel. The electronic device 200 may not include the broadcast receiver 213 according to the embodiment.

The communication unit 210 can receive the user's biometric information from the biometric information measurement device. In addition, the communication unit 210 may transmit the set insulin administration information to the insulin administration apparatus 100 and receive the insulin administration completion information from the insulin administration apparatus 100.

Further, the communication unit 210 can receive the insulin prescription information from the external device. The communication unit 210 may transmit a message including a result of side effects to insulin administration to a predetermined external device.

The output unit 220 is for outputting a video signal, an audio signal, or a vibration signal. The output unit 220 may include a display unit 221, an acoustic output unit 222, a vibration motor 223, and the like.

The display unit 221 displays and outputs information processed by the electronic device 200. For example, the display unit 221 may display information on the insulin administration information, information on the completion of administration of insulin, or a result of determining whether there is an abnormality with respect to insulin administration. The sound output unit 222 may receive or store And outputs the audio data stored in the storage unit 270. [ The sound output unit 222 also outputs sound signals related to functions (e.g., call signal reception sound, message reception sound, alarm sound) performed in the electronic device 200. [ The sound output unit 122 may include a speaker, a buzzer, and the like. For example, the sound output unit 222 may output the result of determining the set insulin dose information, the insulin dose completion information, or the abnormality of the insulin dose.

The vibration motor 223 can output a vibration signal. For example, the vibration motor 223 may output a vibration signal corresponding to an output of audio data or video data (e.g., a call signal reception tone, a message reception tone, etc.). For example, the vibration motor 223 can output information on the completion of insulin administration or the result of the determination of the abnormality with respect to insulin administration. In addition, the vibration motor 223 may output a vibration signal when a touch is input to the touch screen.

The control unit 230 controls the overall operation of the electronic device 200. For example, the control unit 230 may include a communication unit 210, an output unit 220, a user input unit 240, a sensor unit 250, and an A / V input unit (not shown) by executing programs stored in the storage unit 270 260 and so on.

The control unit 230 can set insulin administration information based on the insulin prescription information and the biometric information of the user before administration of the insulin. The control unit 230 may control the display unit 221 to display the set insulin administration information.

The control unit 230 can control the insulin administration to determine whether or not there is an abnormality in administration of insulin based on the obtained biometric information of the user, and to output a result of the determination. For example, the control unit 230 may control the display unit 221 to display the determination result, or output the determination result as audio or vibration.

In addition, if it is determined that the side effect is a result of the determination, the control unit 230 may control a message including a side effect result to be transmitted to a predetermined external device.

The user input unit 240 means a means for the user to input data for controlling the electronic device 200. [ For example, the user input unit 240 may include a key pad, a dome switch, a touch pad (a contact type capacitance type, a pressure type resistive type, an infrared ray detection type, a surface ultrasonic wave conduction type, A tension measuring method, a piezo effect method, etc.), a jog wheel, a jog switch, and the like, but is not limited thereto.

The touch screen 245 may comprise a touch panel and a display panel. The touch screen 245 can be configured to detect not only the touch input position, the touch area, but also the touch pressure. In addition, the touch screen 245 can be configured to detect not only a real-touch but also a proximity touch.

In the present specification, the term " real-touch " refers to a case where a touch tool (e.g., an electronic pen, a finger or the like) is actually touched on the screen and a term " proximity- Refers to a case where the touch tool is not actually touched on the screen but is approached at a predetermined distance from the screen. Although not shown in the drawings, various sensors may be provided in or near the touch screen 245 to sense a touch or proximity touch of the touch screen. An example of a sensor for sensing the touch of the touch screen 245 is a tactile sensor. A tactile sensor is a sensor that detects the contact of a specific object with a degree or more that a person feels. The tactile sensor can detect various information such as the roughness of the contact surface, the rigidity of the contact object, and the temperature of the contact point.

In addition, proximity sensor 258 is an example of a sensor for sensing the touch of the touch screen 245. The proximity sensor 258 refers to a sensor that detects the presence of an object approaching a predetermined detection surface, or the presence of an object in the vicinity thereof, without mechanical contact using the force of an electromagnetic field or infrared rays. Examples of proximity sensors include a transmission type photoelectric sensor, a direct reflection type photoelectric sensor, a mirror reflection type photoelectric sensor, a high frequency oscillation type proximity sensor, a capacitive proximity sensor, a magnetic proximity sensor, and an infrared proximity sensor. The sensor unit 250 may detect the state of the electronic device 200 or the state of the electronic device 200. For example, the touch sensor 220 may be a touch sensor, 200 and may transmit the sensed information to the control unit 230. [0033] FIG.

The sensor unit 250 includes a magnetic sensor 251, an acceleration sensor 252, an on / humidity sensor 153, an infrared sensor 254, a gyroscope sensor 255, (GPS) 256, an air pressure sensor 257, a proximity sensor 258, and an RGB sensor (illuminance sensor) 259. However, the present invention is not limited thereto. The function of each sensor can be intuitively deduced from the name by those skilled in the art, so a detailed description will be omitted.

The sensor unit 250 may sense a movement of the electronic device 200, a bio-signal of the electronic device user, a touch signal input to the electronic device, and the like.

The A / V (Audio / Video) input unit 260 is for inputting an audio signal or a video signal, and may include a camera 261 and a microphone 262. The camera 261 can obtain an image frame such as a still image or a moving image through the image sensor in the video communication mode or the photographing mode. The image captured through the image sensor can be processed through the control unit 220 or a separate image processing unit (not shown).

The image frame processed by the camera 261 may be stored in the storage unit 270 or transmitted through the communication unit 250 to the outside. The camera 261 may be equipped with two or more cameras according to the configuration of the electronic device 200.

The microphone 262 receives an external acoustic signal and processes it as electrical voice data. For example, the microphone 262 may receive acoustic signals from an external device or speaker. The microphone 262 may use various noise reduction algorithms to remove noise generated in receiving an external sound signal.

The storage unit 270 may store a program for processing and controlling the control unit 230, and may store input / output data. The storage unit 270 according to one embodiment may store information on a user's insulin administration history. For example, the time of insulin administration (date, time, etc.), the type of insulin administered, the amount of insulin administered, and the like can be stored. The control unit 230 may update the insulin administration history information stored in the storage unit 270 every time the insulin administration completion information is received from the insulin administration apparatus 100. [

The storage unit 270 may be a flash memory type, a hard disk type, a multimedia card micro type, a card type memory (for example, SD or XD memory) (Random Access Memory) SRAM (Static Random Access Memory), ROM (Read Only Memory), EEPROM (Electrically Erasable Programmable Read-Only Memory), PROM (Programmable Read-Only Memory) A disk, and / or an optical disk. Also, the electronic device 200 may operate a web storage or a cloud server that performs a storage function of the storage unit 270 on the Internet.

Programs stored in the storage unit 270 can be classified into a plurality of modules according to their functions. For example, the programs can be classified into a UI module 271, a touch screen module 272, a notification module 273, have.

The UI module 271 can provide a specialized UI, a GUI, and the like that are interlocked with the electronic device 200 for each application. The touch screen module 272 senses a touch gesture on the user's touch screen and can transmit information on the touch gesture to the control unit 230. [ The touch screen module 272 according to an embodiment of the present invention can recognize and analyze the touch code. The touch screen module 272 may be configured as separate hardware including a controller.

The notification module 273 may generate a signal for notifying the occurrence of an event of the electronic device 200. [ Examples of events generated in the electronic device 200 include call signal reception, message reception, key signal input, schedule notification, and the like. The notification module 273 may output a notification signal in the form of a video signal through the display unit 221 or may output a notification signal in the form of an audio signal through the sound output unit 222, It is possible to output a notification signal in the form of a vibration signal.

The image display method according to one embodiment may be implemented in the form of a program command that can be executed through various computer means and recorded in a computer readable medium. The computer-readable medium may include program instructions, data files, data structures, and the like, alone or in combination. The program instructions recorded on the medium may be those specially designed and constructed for the present invention or may be available to those skilled in the art of computer software. Examples of computer-readable media include magnetic media such as hard disks, floppy disks and magnetic tape; optical media such as CD-ROMs and DVDs; magnetic media such as floppy disks; Magneto-optical media, and hardware devices specifically configured to store and execute program instructions such as ROM, RAM, flash memory, and the like. Examples of program instructions include machine language code such as those produced by a compiler, as well as high-level language code that can be executed by a computer using an interpreter or the like.

While the present invention has been particularly shown and described with reference to exemplary embodiments, it is to be understood that the invention is not limited to the disclosed exemplary embodiments, but, on the contrary, .

Claims (14)

A communication unit for requesting measurement of the user's biometric information by the biometric information measuring apparatus and receiving the biometric information from the biometric information measuring apparatus when the completion of insulin administration is detected;
A controller for determining whether the user is abnormal based on the received biometric information; And
And an output unit for outputting a result of the determination as to whether or not the abnormality is present. The method according to claim 1,
Wherein,
Insulin administration information is set based on the biometric information of the user measured before administration of the insulin and the insulin prescription information for the user,
The insulin administration information
An insulin administration time, a type of insulin to be administered, an insulin dose, and a mixing ratio of insulin. 3. The method of claim 2,
Wherein,
And receives the insulin prescription information from an external device. 3. The method of claim 2,
The apparatus comprises:
And a user input unit for receiving the insulin prescription information. 3. The method of claim 2,
The output unit includes:
And a display unit for displaying the set insulin administration information. The method according to claim 1,
The output unit includes:
And displays the result of the determination on the display unit or outputs the result as audio or vibration. The method according to claim 1,
The apparatus comprises:
Further comprising a sensor unit for sensing whether or not a needle coupled to the insulin administration device is in contact with the user's body,
Wherein,
Wherein the insulin administration device determines that the insulin administration is completed when the needle is not in contact with the user's body for a time set by the user. The method according to claim 1,
Wherein,
Wherein the insulin administration device determines that the administration of the insulin is completed when at least one of the administration of the insulin dosage amount included in the set insulin administration information and the reception of the insulin administration completion input is received. Detecting completion of insulin administration;
Requesting measurement of the user's biometric information by the biometric information measuring device;
Receiving biometric information from the biometric information measuring device;
Determining whether the user is abnormal based on the received biometric information; And
And outputting a result of the determination as to whether or not the abnormality is present. A communication unit for receiving information on completion of insulin administration from the insulin administration device and requesting the biometric information measurement device to measure the user's biometric information upon receipt of the insulin administration completion information and receiving the biometric information from the biometric information measurement device;
A controller for determining whether the user is abnormal based on the received biometric information; And
And an output unit for outputting a result of the determination as to whether there is an abnormality. 11. The method of claim 10,
The electronic device includes:
And a storage unit for storing insulin administration history information of the user,
Wherein the control unit updates the insulin administration history information when receiving the insulin administration completion information. 11. The method of claim 10,
Wherein,
And receives the insulin prescription information for the user from the prescription server. 11. The method of claim 10,
Wherein,
And to transmit the message to the terminal set by the user through the communication unit when it is determined that there is an anomaly for the user as a result of the determination. Receiving insulin administration completion information from the insulin administration device;
Requesting measurement of the user's biometric information by the biometric information measuring device upon receiving the insulin administration completion information;
Receiving biometric information from the biometric information measuring device;
Determining whether the user is abnormal based on the received biometric information; And
And outputting a result of the determination as to whether there is an abnormality.

Images